Case study from Innovation: early diagnosis in community settings

A pharmacy-based intervention could prevent heart failure in primary care, US

8 December, 2022

What is the aim?

The study uses the PCP-HF protocol to predict heart failure risk of 5% or higher over a 10-year period using measures available in primary care settings. People at risk of heart failure will be monitored with biomarker testing and echocardiography as well as health and lifestyle questionnaires.

What has been achieved?

The study is ongoing. Participants have been assigned to usual care or one-year pharmacist-led interventions in which a pharmacist, under the supervision of a cardiologist, recommends therapy initiation and adjustments to optimise the management of heart failure risk factors (e.g. hypertension, cholesterol).


Wang MC, Dolan B, Freed BH, et al. 2021. Rationale and Design of a Pharmacist-led Intervention for the Risk-Based Prevention of Heart Failure: The FIT-HF Pilot Study. Front Cardiovasc Med 8: 785109

Back to the Project
The Heart Failure Policy Network is an independent, multidisciplinary platform made possible with financial support from AstraZeneca and Roche Diagnostics. The content produced by the Network is not biased toward any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members. All members provide their time for free. The Network is hosted by The Health Policy Partnership .